Two Sigma Advisers’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.45M | Buy |
256,800
+65,000
| +34% | +$1.13M | 0.01% | 781 |
|
|
2025
Q1 | $4.19M | Buy |
+191,800
| New | +$4.19M | 0.01% | 853 |
|
|
2022
Q1 | – | Sell |
-30,600
| Closed | -$1.45M | – | 2724 |
|
|
2021
Q4 | $1.45M | Sell |
30,600
-461,000
| -94% | -$21.8M | ﹤0.01% | 1356 |
|
|
2021
Q3 | $16.2M | Sell |
491,600
-132,300
| -21% | -$4.36M | 0.04% | 365 |
|
|
2021
Q2 | $39.4M | Sell |
623,900
-63,500
| -9% | -$4.01M | 0.1% | 203 |
|
|
2021
Q1 | $29.5M | Sell |
687,400
-21,200
| -3% | -$910K | 0.08% | 262 |
|
|
2020
Q4 | $40.5M | Sell |
708,600
-103,600
| -13% | -$5.93M | 0.11% | 202 |
|
|
2020
Q3 | $24.5M | Sell |
812,200
-109,000
| -12% | -$3.29M | 0.07% | 268 |
|
|
2020
Q2 | $30.1M | Buy |
921,200
+44,000
| +5% | +$1.44M | 0.09% | 238 |
|
|
2020
Q1 | $23.5M | Buy |
877,200
+617,200
| +237% | +$16.5M | 0.09% | 260 |
|
|
2019
Q4 | $7.96M | Buy |
260,000
+189,300
| +268% | +$5.8M | 0.02% | 668 |
|
|
2019
Q3 | $1.7M | Buy |
+70,700
| New | +$1.7M | ﹤0.01% | 1181 |
|